—
C+
C+ The full Closelooknet — membership. Open the C+ overview

GALDERMA GROUP AG (GALDY) — chart, structure and Closelooknet read

The Closelooknet read

Galderma is a dermatology company that groups its work into three areas: injectable aesthetics such as Dysport and Restylane, dermatological skincare brands including Cetaphil, and therapeutic dermatology treatments like Differin and NEMLUVIO. It sells worldwide, was founded in 1981 and is based in Zug, Switzerland.

Detail below: the desk's view, the earnings record, peers and the company snapshot; daily prices on the price-history tab. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for GALDY, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 46/100 · S&P 500 fund at 50, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-11-02
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 76th percentile of the window, -20.6% over 20 sessions. Factor regime → 2026-11-02
  • Sector × region Health care in US: +3.0% week · +11.1% month · +14.3% quarter · +26.9% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-11-02
  • Sovereign pressure Index -1.63 · down 2.22 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-11-02
How it trades on rate days beta 1.33 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How GALDY has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 1.33 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), GALDERMA GROUP AG moved 1.33% on average · correlation 0.40 · higher than 92% of US names
  • Beta, last 3 months 1.69 more rate-sensitive lately than over the year
  • On the 10 worst bond days −1.19% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +1.24% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Drug Manufacturers - Specialty & Generic · US · 8 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic · US

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against GALDY on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — GALDERMA GROUP AG

GALDY in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Galderma is a dermatology company that groups its work into three areas: injectable aesthetics such as Dysport and Restylane, dermatological skincare brands including Cetaphil, and therapeutic dermatology treatments like Differin and NEMLUVIO. It sells worldwide, was founded in 1981 and is based in Zug, Switzerland.
Where it sits in the stack
Galderma carries no seat in our Rubin or Halo indices; it sits in the Healthcare sleeve of Closelooknet's wider universe, scored alongside other US-listed healthcare names rather than tracked as a build-out constituent.
Who it is priced against
Closelooknet's peer group places it with other scored US Healthcare names, chosen for shared sector and country rather than shared products — argenx, Regeneron, Vertex and Corcept among them; the market also names AbbVie's aesthetics business as a comparable competitor.
Why Closelooknet tracks it
It carries a Closelooknet score with quality the strongest module and valuation the weakest; it holds no index seat and has drawn no quotes yet in our editions.
What the diary watches
Whether the gap between its firmer quality reading and its softer valuation reading narrows, and whether the recent slide below its 50- and 200-day levels persists.

GALDERMA GROUP AG (GALDY) trades on US exchanges, classified under Healthcare.

The Closelooknet company score reads 56/100 composite (momentum 71, quality 59, valuation 22) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 0.14%, annual · buybacks 363 m USD in FY2025

Dividends and capital return

What GALDY pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.0666 USD per share · a 0.14% yield on the 2026-11-02 close 1 distribution, paid once a year 2026-11-02
  • Change on the year +223.3% against the prior twelve months prior twelve months 0.0206 USD per share
  • Last distribution 0.0666 USD per share as the price series records it, within days of the ex-date 2026-04-27
  • By calendar year 2025: 0.0206 USD (partial) · 2026: 0.0666 USD to date first distribution recorded in the three-year window: 2025-04-28
  • Dividends paid, FY2025 41 m USD 12% of earnings
  • Buybacks, FY2025 363 m USD 0.7% of today's market value
  • Share count −1.2% in FY2025 64 m USD of stock-based compensation in the year
  • Capital returned 404 m USD · 39% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-11-03

Quick answers

What is GALDERMA GROUP AG (GALDY)?

GALDERMA GROUP AG trades as GALDY on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-11-03.

Is GALDY in a Closelooknet index?

Not currently — GALDERMA GROUP AG is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-03.

What is GALDERMA GROUP AG's Closelooknet composite score?

56 out of 100, with momentum 71, quality 59 and valuation 22 sub-scores, as of 2026-11-03. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does GALDY trade against its moving averages?

GALDERMA GROUP AG trades 14.0% above its 50-day and 14.1% above its 200-day moving average (8.8% above its 20-day). As of 2026-11-02 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does GALDERMA GROUP AG compare with its peers?

Against its peer group (Drug Manufacturers - Specialty & Generic · US), GALDERMA GROUP AG (GALDY) sits 1.0% below its 52-week high, 14.0% above its 50-day average; Lantheus Holdings Inc (LNTH) is 10.3% below, Kiniksa Pharmaceuticals Ltd (KNSA) is 7.8% below, Ironwood Pharmaceuticals Inc (IRWD) is 40.1% below, as of 2026-11-02. Put any of them next to GALDY in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does GALDERMA GROUP AG trade when bond yields rise?

Over the past year GALDERMA GROUP AG had a beta of 1.33 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 92% of US names. On the 10 sessions in which long bonds fell most it moved −1.19% on average, against −0.74% for the S&P 500. As of 2026-11-02; The "How it trades on rate days" block on this page carries the lines.

What does GALDERMA GROUP AG do?

Galderma is a dermatology company that groups its work into three areas: injectable aesthetics such as Dysport and Restylane, dermatological skincare brands including Cetaphil, and therapeutic dermatology treatments like Differin and NEMLUVIO. It sells worldwide, was founded in 1981 and is based in Zug, Switzerland. Closelooknet's peer group places it with other scored US Healthcare names, chosen for shared sector and country rather than shared products — argenx, Regeneron, Vertex and Corcept among them; the market also names AbbVie's aesthetics business as a comparable competitor. (Company snapshot of 2026-09-17.)

Where does GALDERMA GROUP AG sit in the AI build-out?

Galderma carries no seat in our Rubin or Halo indices; it sits in the Healthcare sleeve of Closelooknet's wider universe, scored alongside other US-listed healthcare names rather than tracked as a build-out constituent. It carries a Closelooknet score with quality the strongest module and valuation the weakest; it holds no index seat and has drawn no quotes yet in our editions. (Company snapshot of 2026-09-17.)

Does GALDERMA GROUP AG pay a dividend?

GALDERMA GROUP AG has paid 0.0666 USD per share over the last twelve months, paid once a year, a trailing yield of 0.14% on the 2026-11-02 close; the last distribution recorded in the price series was 0.0666 USD on 2026-04-27. In fiscal 2025 the company paid 41 m USD in dividends and bought back 363 m USD of its own shares, 39% of that year’s free cash flow. The share count fell 1.2% over the fiscal year. As of 2026-11-02; the "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for GALDY, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

How to use this chart

Toolbar

  • Range — 1M to MAX on daily closes. 1D/5D switch a US stock cell to 5-minute intraday bars; index and foreign cells fall back to 1M daily with a note.
  • Grid — 1×1 up to 2×2. Cells are synchronized: pan or zoom one and the others follow the same dates; the crosshair tracks across all of them. 4 INDICES loads Rubin · HALO · AEI · AW40 side by side.
  • Type / Scale — OHLC, line or area; linear or log price axis.

Picking a series

  • Tap the box in a cell's header to browse every Closelooknet series — headline indices, sub-indices, sectors, layers of all six families — plus the constituents.
  • Or type any ticker (NVDA, 7203.T, ASML.AS …) and press Enter — it charts in the cell straight from our data lake.

Studies

  • Overlays / Oscillators rows toggle the standard set (SMA, Bollinger, RSI, MACD …) per cell.
  • Levels (stock cells) draws the structure engine's support lines — regression bands, pivot cluster, SMA-200, the active fib zone.

Drawing

  • Tap a tool (Trend, Ray, H-Line, Fib, Channel, Rect, Note), then tap the chart once per point — the shape follows your finger or cursor between taps. The chart stops panning while a tool is armed; tap the tool again to release.
  • Drawings save per symbol in this browser and travel between the terminal and the asset page.
  • Delete key removes the selected drawing · Escape cancels a half-placed one · Clear wipes the symbol.

Wave counts

  • Wave places an Elliott count: tap the origin, then each wave end. Press Enter to stop early (inside wave 3 is fine) — dotted ghost targets sketch the remaining waves at guideline ratios.
  • On stocks the scanner's machine count appears automatically in grey — it is fully editable: drag any point, double-tap a label to remove it, Delete to dismiss it for good, Adopt to bring the machine's proposal back.
  • The sequence picker switches 1-5 / A-B-C / A-E / W-X-Y-Z; 1 2 3 cycles the degree; Subdiv starts a one-degree-smaller child count inside a wave.

Sharing

  • Card exports the cell as a branded PNG — chart, drawings and levels exactly as shown.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.